Skip to main content
. 2014 Mar 18;9(3):e92319. doi: 10.1371/journal.pone.0092319

Table 3. Contribution of biochemical and physical variables to a model predicting infection in systemically inflamed neutropenic hematology patients.

Variable Patient group with highest level of analyte Included in model
Name Short name Impor-tancea 55-variable 40-variable
S-Procalcitonin Procalc 2.5 Infectedb X X
S-Urea Urea 2.3 Non-infectedb X X
B-White blood cell count WBC 2.3 Infected X X
S-Interleukin-10 IL-10 2.2 Infected X X
S-Bilirubin Bil 2.0 Infected X X
S-Interleukin-8 IL-8 1.9 Infected X X
P-Factor XII (Hageman factor) XII 1.9 Non-infected X X
B-Erythrocyte volume fraction EVF 1.8 Non-infected X X
S-Bilirubin (conjugated) BilC 1.8 Infected X X
B-Hemoglobin Hb 1.7 Non-infected X X
Current smoker Smok 1.7 Non-infected X X
S-Cortisol Cort 1.7 Infected X X
B-Lymphocyte count Lymph 1.6 Non-infected X
P-Plasminogen activator inhibitor-1 PAI 1.6 Infected X X
P-von Willebrand factor vWF 1.6 Infected X X
S-High mobility group box protein-1 HMGB 1.6 Non-infected X X
S-Prohepcidin Prohep 1.5 Infected X X
S-Low-density lipoprotein LDL 1.5 Non-infected X X
B-Neutrophil count Neu 1.5 Non-infected X
S-C4b-binding protein (β-chain-containing isoform) C4BPb 1.4 Non-infected X X
S-Cystatin C CysC 1.4 Infected X X
P-Glucose Glu 1.4 Infected X
P-Protein S Prot S 1.4 Non-infected X X
Cyclosporin A treatment CyA 1.3 Infected X X
S-Hepcidin Hepc 1.3 Infected X X
B-Mean corpuscular hemoglobin concentration MCHC 1.3 Infected X X
B-Eosinophil count Eos 1.3 Non-infected X
S-Alpha fetoprotein AFP 1.3 Infected X X
S-Lactate dehydrogenase LD 1.3 Non-infected X
Blood pressure (diastolic) BPd 1.3 Non-infected X X
S-Cholesterol Chol 1.3 Non-infected X X
B-Reticulocyte count Ret 1.3 Non-infected X X
S-Immunoglobulin E IgE 1.3 Non-infected X
Peripheral vein sampling Per 1.2 Non-infected X X
Port-a-catheter PAC 1.2 Infected X X
S-Interleukin-1 IL-1 1.2 Infected X X
B-Mean corpuscular volume MCV 1.2 Non-infected X X
B-International Normalized Ratio ( =  prothrombin time) INR 1.2 Infected X X
P-Factor X X 1.2 Non-infected X X
B-Monocyte count Mono 1.2 Non-infected X
S-C-reactive protein CRP 1.2 Infected X X
S-Ferritin Ferri 1.1 Infected X
S-Potassium K 1.1 Infected X
S-Hemopexin Hpx 1.1 Non-infected X
S-Troponin T TropT 1.1 Infected X X
B-Hemoglobin A HbA 1.1 Non-infected X
S-Transferrin Trans 1.1 Non-infected X X
S-Immunoglobulin M IgM 1.0 Infected X
S-Sodium Na 1.0 Non-infected X X
B-Basophil count Bas 1.0 Non-infected X
B-Erythrocyte particle concentration EPC 1.0 Non-infected X X
S-Orosomucoid Oro 1.0 Non-infected X
P-Activated partial thromboplastin time APTT 1.0 Infected X X
S-Thyroid stimulatory hormone TSH 1.0 Non-infected X
S-Total iron binding capacity TIBC 1.0 Non-infected X X
Allogeneic transplant recipient Allo 0.97
P-Coagulation factor II (prothrombin) II 0.96
Erythrocyte sedimentation rate SR 0.91
S-High density lipoprotein HDL 0.88
S-Chloride Cl 0.85
S-Amylase, pancreatic AmyP 0.83
S-Alanine aminotransferase ALT 0.81
S-Immunoglobulin G IgG 0.79
S-Albumin Alb 0.79
B-Platelet count PC 0.78
P-Coagulation factor VII VII 0.72
S-Testosterone Test 0.71
S-Interleukin-6 IL-6 0.70
S-Triiodothyronine T3 0.69
S-Creatinine Crea 0.68
S-Leptin Lep 0.68
S-Myoglobin Myo 0.67
Blood pressure, systolic BPs 0.67
S-Tetraiodothyronine T4 0.67
S-Tumor necrosis factor TNF 0.65
S-Estrogen Est 0.65
S-Protein Prot 0.64
Patient fasting prior to blood sampling Fast 0.63
S-Creatine kinase, muscle brain CKM 0.63
S-Transferrin saturation TransS 0.60
P-Factor XI XI 0.60
S-Triglycerides TG 0.60
S-α2-macroglobulin a2M 0.59
S-Aspartate aminotransferase AST 0.59
S-Soluble transferrin receptor TfR 0.57
Body length Leng 0.56
P-Protein C ProtC 0.55
Cytarabine treatment, current Cytar 0.53
S-Iron Fe 0.52
No of fever days prior to inclusion Fday 0.52
S-Urate Urate 0.52
S-Insulin growth factor-1 IGF-1 0.51
Peripheral vein catheter PVC 0.50
S-Ceruloplasmin Cer 0.49
Body weight Wt 0.48
S-Phosphate P 0.48
S-Haptoglobin Hap 0.47
P-Factor VIII VIII 0.47
S-Immunoglobulin A IgA 0.47
Autologous transplant recipient Auto 0.47
S-Alkaline phosphatase ALP 0.46
Heart rate HR 0.45
B-Erythrocyte mean corpuscular hemoglobin MCH 0.44
P-Coagulation factor V V 0.39
S-Tetratiodothyronine, free T4f 0.39
S-Adiponectin Adip 0.38
S-Prostate specific antigen, free PSAf 0.37
S-γ-Glutamyl transferase gGT 0.32
P-Dimerized plasmin fragment D Dim 0.32
S-Thyroxin-binding globulin TBG 0.32
Age Age 0.28
P-Erythropoietin EPO 0.27
Central venous catheter CVC 0.27
S-Interferon-γ IFNg 0.27
S-Triiodothyronine, free T3f 0.26
Hypogammaglobulinemia Hypog 0.26
S-Calcium Ca 0.25
S-Amyloid A SAA 0.24
S-Fibrinogen Fibrino 0.24
Temperature Temp 0.22
Presence of chills Chills 0.20
Peripheral oxygen saturation POX 0.19
S-Interleukin-17 IL-17 0.19
S-C4b-binding protein-α chain C4BPa 0.18
S-Complement factor 3 C3 0.17
Sex Sex 0.16
S-Lactoferrin Lact 0.16
P-anti-thrombin a-thrombin 0.14
S-Amylase, total AmyT 0.14
S-Creatine kinase CK 0.14
S-Magnesium Mg 0.14
S-Prostate-specific antigen PSA 0.093
S-Total complement complex TCC 0.076
Corticosteroid therapy Co 0.066
P-Renin Ren 0.056
S-α1-antitrypsin AT 0.032
S-Complement factor 4 C4 0.025
S-NT pro-brain natriuretic peptide pBNP 0.015
P-Factor IX IX 0.0051

Abbreviations: S  =  serum, P  =  blood plasma, B  =  blood.

a

The relative importance of each variable to the 139-variable model was determined using the “Variable importance” module in the SIMCA software.

b

Patients were classified as infected or non-infected by an independent infectious disease specialist blinded to the results of the biochemical analyses